PatientsVille.com Logo

Gatifloxacin Side Effects

PatientsVille

Common Gatifloxacin Side Effects


The most commonly reported Gatifloxacin side effects (click to view or check a box to report):

Hypoglycaemia (122)
Hyperglycaemia (55)
Diarrhoea (23)
Blood Glucose Increased (14)
Convulsion (14)
Anaphylactic Shock (13)
Dyspnoea (11)
Loss Of Consciousness (11)
Dizziness (11)
Rash (10)
Clostridium Colitis (9)
Pyrexia (9)
Confusional State (9)
Nausea (8)
Renal Failure (8)
Depressed Level Of Consciousness (7)
Electrocardiogram Qt Prolonged (7)
Platelet Count Decreased (7)
Hallucination (7)
Hypoglycaemic Coma (7)

➢ More



If you or someone in your family has experienced a serious side effect to a health product, you are encouraged to report the experience to your health care professional (e.g. physician, pharmacist). You could also complete a copy of the side effect reporting form or report your side effect to FDA.

Gatifloxacin Side Effects Reported to FDA



Gatifloxacin Side Effect Report#9607397
Immune System Disorder, Impaired Healing, Raynaud^s Phenomenon, Fibromyalgia, Neuropathy Peripheral, Fatigue, Cluster Headache, Visual Impairment, Skin Infection
This is a report of a 52-year-old male patient (weight: NA) from US, suffering from the following health symptoms/conditions: prostatitis, who was treated with Gatifloxacin (dosage: NA, start time: NS), combined with: NA. and developed a serious reaction and side effect(s): Immune System Disorder, Impaired Healing, Raynaud^s Phenomenon, Fibromyalgia, Neuropathy Peripheral, Fatigue, Cluster Headache, Visual Impairment, Skin Infection after the beginning of treatment. This case can indicate the possible existence of increased vulnerability to Gatifloxacin treatment in male patients, resulting in Immune System Disorder side effect.
Gatifloxacin Side Effect Report#9261995
Pyrexia, Asthenia, Influenza Like Illness, Stevens-johnson Syndrome
This report suggests a potential Gatifloxacin Sesquihydrate Unk Death side effect(s) that can have serious consequences. A 67-year-old male patient (weight: NA) from CA was diagnosed with the following symptoms/conditions: stevens-johnson syndrome and used Gatifloxacin Sesquihydrate Unk (dosage: NA) starting NS. After starting Gatifloxacin Sesquihydrate Unk the patient began experiencing various side effects, including: Pyrexia, Asthenia, Influenza Like Illness, Stevens-johnson SyndromeAdditional drugs used concurrently:
  • Moxifloxacin (Unk)
  • Corticosteroids
  • Immunoglobulin
Although Gatifloxacin Sesquihydrate Unk demonstrated significant improvements in a number of clinically relevant cases, troublesome symptoms, such as Death, may still occur.
Gatifloxacin Side Effect Report#8266238-0
Prostate Infection
This Prostate Infection problem was reported by a physician from China. A 29-year-old male patient (weight: NA) was diagnosed with the following symptoms/conditions: urethritis. On NS this consumer started treatment with Gatifloxacin (dosage: NA). The following drugs were being taken at the same time: NA. When using Gatifloxacin, the patient experienced the following unwanted symptoms/side effects: Prostate InfectionAlthough all drugs are carefully tested before they are licensed for use, they carry side effect risks. Some side effects, such as Prostate Infection, may become evident only after a product is in use by the general population.
Gatifloxacin Side Effect Report#7543928-6
Corneal Erosion
This Corneal Erosion side effect was reported by a consumer or non-health professional from Switzerland. A 61-year-old male patient (weight:NA) experienced the following symptoms/conditions: NA.The patient was prescribed Gatifloxacin (drug dosage: NA), which was initiated on
May 27, 2011. Concurrently used drugs:
  • Lidocaine
  • Tetracycline Hcl
  • Isodine (Unk)
  • Benoxinate Hydrochloride (Unk)
  • Lucentis (Unk)
  • Ofloxacin
  • Chlorhexidine Nos
.After starting to take Gatifloxacin the consumer reported adverse symptoms, such as: Corneal ErosionThese side effects may potentially be related to Gatifloxacin. The patient was hospitalized.
Gatifloxacin Side Effect Report#7503718-7
Vomiting, Visual Acuity Reduced, Intraocular Pressure Increased, Corneal Opacity, Angle Closure Glaucoma, Eye Pain
This is a report of a 62-year-old male patient (weight: NA) from United Kingdom, suffering from the following health symptoms/conditions: NA, who was treated with Gatifloxacin (dosage: NA, start time: NS), combined with:
  • Tobramycin (Ophthalmic)
  • Dexamethasone Sodium Phosphate (Ophthalmic)
  • Tamsulosin Hcl (Ophthalmic)
  • Cyclopentolate Hcl (Ophthalmic)
  • Homatropine
and developed a serious reaction and side effect(s): Vomiting, Visual Acuity Reduced, Intraocular Pressure Increased, Corneal Opacity, Angle Closure Glaucoma, Eye Pain after the beginning of treatment. This case can indicate the possible existence of increased vulnerability to Gatifloxacin treatment in male patients, resulting in Vomiting side effect.
Gatifloxacin Side Effect Report#7283504-6
Corneal Oedema, Intraocular Pressure Increased, Corneal Opacity, Corneal Disorder, Visual Acuity Reduced
This report suggests a potential Gatifloxacin Corneal Oedema side effect(s) that can have serious consequences. A 68-year-old male patient (weight: NA) from Japan was diagnosed with the following symptoms/conditions: NA and used Gatifloxacin (dosage: Two Times) starting
Oct 09, 2010. After starting Gatifloxacin the patient began experiencing various side effects, including: Corneal Oedema, Intraocular Pressure Increased, Corneal Opacity, Corneal Disorder, Visual Acuity ReducedAdditional drugs used concurrently:
  • Candesartan (Unk)
  • Betamethasone (Unk)
  • Diclofenac Sodium (Unk)
  • Tropicamide (Unk)
  • Betamethasone (Unk)
  • Betamethasone (Unk)
Although Gatifloxacin demonstrated significant improvements in a number of clinically relevant cases, troublesome symptoms, such as Corneal Oedema, may still occur.
Gatifloxacin Side Effect Report#7271209-7
Corneal Opacity, Intraocular Pressure Increased, Visual Acuity Reduced, Corneal Oedema, Corneal Disorder
This Corneal Opacity problem was reported by a physician from Japan. A 68-year-old male patient (weight: NA) was diagnosed with the following symptoms/conditions: cataract operation. On
Oct 23, 2010 this consumer started treatment with Gatifloxacin (dosage: Four Times). The following drugs were being taken at the same time:
  • Cefdinir
  • Dilazep Dihydrochloride (Unk)
  • Betamethasone (Unk)
  • Betamethasone (Unk)
  • Diclofenac Sodium (Unk)
  • Tropicamide (Unk)
When using Gatifloxacin, the patient experienced the following unwanted symptoms/side effects: Corneal Opacity, Intraocular Pressure Increased, Visual Acuity Reduced, Corneal Oedema, Corneal DisorderAlthough all drugs are carefully tested before they are licensed for use, they carry side effect risks. Some side effects, such as Corneal Opacity, may become evident only after a product is in use by the general population.
Gatifloxacin Side Effect Report#6790275-6
Cataract, Intraocular Pressure Increased
This Cataract side effect was reported by a physician from Hungary. A 49-year-old female patient (weight:NA) experienced the following symptoms/conditions: eye pain.The patient was prescribed Gatifloxacin Sesquihydrate Unk (drug dosage: NA), which was initiated on NS. Concurrently used drugs:
  • Natamycin
.After starting to take Gatifloxacin Sesquihydrate Unk the consumer reported adverse symptoms, such as: Cataract, Intraocular Pressure IncreasedThese side effects may potentially be related to Gatifloxacin Sesquihydrate Unk.
Gatifloxacin Side Effect Report#6780399-1
Corneal Disorder, Corneal Infiltrates, Corneal Oedema, Eye Infection, Hypopyon
This is a report of a 43-year-old male patient (weight: NA) from United States, suffering from the following health symptoms/conditions: eye infection, who was treated with Gatifloxacin Sesquihydrate Unk (dosage: 1 Gtt, Q2hr, start time: NS), combined with:
  • Natamycin (Unk)
  • Fluconazole (100 Mg, Bid)
  • Voriconazole (Unk)
  • Voriconazole (200 Mg, Bid)
  • Acuvue (Unk)
and developed a serious reaction and side effect(s): Corneal Disorder, Corneal Infiltrates, Corneal Oedema, Eye Infection, Hypopyon after the beginning of treatment. This case can indicate the possible existence of increased vulnerability to Gatifloxacin Sesquihydrate Unk treatment in male patients, resulting in Corneal Disorder side effect. The patient was hospitalized.
Gatifloxacin Side Effect Report#6696261-9
Anaphylactic Reaction
This report suggests a potential Gatifloxacin Anaphylactic Reaction side effect(s) that can have serious consequences. A 3-year-old female patient (weight: NA) from Japan was diagnosed with the following symptoms/conditions: NA and used Gatifloxacin (dosage: NA) starting NS. After starting Gatifloxacin the patient began experiencing various side effects, including: Anaphylactic ReactionAdditional drugs used concurrently: NA. Although Gatifloxacin demonstrated significant improvements in a number of clinically relevant cases, troublesome symptoms, such as Anaphylactic Reaction, may still occur.
Gatifloxacin Side Effect Report#6597793-4
Corneal Epithelium Defect, Eye Pain, Keratitis Fungal
This Corneal Epithelium Defect problem was reported by a physician from Malaysia. A 37-year-old male patient (weight: NA) was diagnosed with the following symptoms/conditions: NA. On NS this consumer started treatment with Gatifloxacin Sesquihydrate Unk (dosage: Unk). The following drugs were being taken at the same time:
  • Prednisolone Acetate Sus (Unk)
When using Gatifloxacin Sesquihydrate Unk, the patient experienced the following unwanted symptoms/side effects: Corneal Epithelium Defect, Eye Pain, Keratitis FungalAlthough all drugs are carefully tested before they are licensed for use, they carry side effect risks. Some side effects, such as Corneal Epithelium Defect, may become evident only after a product is in use by the general population.
Gatifloxacin Side Effect Report#6433101-7
Endophthalmitis, Myopia, Vitreous Opacities
This Endophthalmitis side effect was reported by a physician from United States. A 37-year-old female patient (weight:NA) experienced the following symptoms/conditions: preoperative care,vision blurred,ocular hyperaemia,photophobia.The patient was prescribed Gatifloxacin (drug dosage: Every 5 Minutes For A Total Of 3 Doses 1 Hour), which was initiated on NS. Concurrently used drugs: NA..After starting to take Gatifloxacin the consumer reported adverse symptoms, such as: Endophthalmitis, Myopia, Vitreous OpacitiesThese side effects may potentially be related to Gatifloxacin.
Gatifloxacin Side Effect Report#6356078-1
Hypoglycaemia
This is a report of a 88-year-old female patient (weight: NA) from Japan, suffering from the following health symptoms/conditions: cystitis, who was treated with Gatifloxacin (dosage: NA, start time:
Sep 04, 2009), combined with:
  • Vesicare (Taken As Tabs)
  • Euglucon (Tabs)
  • Amlodipine (Tabs)
  • Allorin (Tabs)
  • Furosemide (Tabs)
  • Ketas (Formulation=capsule)
  • Protecadin (Tabs)
and developed a serious reaction and side effect(s): Hypoglycaemia after the beginning of treatment. This case can indicate the possible existence of increased vulnerability to Gatifloxacin treatment in female patients, resulting in Hypoglycaemia side effect. The patient was hospitalized.
Gatifloxacin Side Effect Report#6238105-5
Conjunctival Hyperaemia, Corneal Epithelium Defect, Corneal Opacity, Hypermetropia
This report suggests a potential Gatifloxacin Conjunctival Hyperaemia side effect(s) that can have serious consequences. A 9-year-old male patient (weight: NA) from Japan was diagnosed with the following symptoms/conditions: conjunctival hyperaemia,corneal epithelium defect,corneal opacity and used Gatifloxacin (dosage: Unk, Q2hr) starting
Nov 01, 2007. After starting Gatifloxacin the patient began experiencing various side effects, including: Conjunctival Hyperaemia, Corneal Epithelium Defect, Corneal Opacity, HypermetropiaAdditional drugs used concurrently: NA.The patient was hospitalized. Although Gatifloxacin demonstrated significant improvements in a number of clinically relevant cases, troublesome symptoms, such as Conjunctival Hyperaemia, may still occur.
Gatifloxacin Side Effect Report#6231882-9
Tubulointerstitial Nephritis
This Tubulointerstitial Nephritis problem was reported by a physician from Japan. A 47-year-old female patient (weight: NA) was diagnosed with the following symptoms/conditions: nasopharyngitis. On
Feb 06, 2009 this consumer started treatment with Gatifloxacin (dosage: NA). The following drugs were being taken at the same time:
  • Meiact
  • Tamiflu
  • Calonal
  • Cefamezin
  • Exacin
  • Optiray 350
When using Gatifloxacin, the patient experienced the following unwanted symptoms/side effects: Tubulointerstitial NephritisThe patient was hospitalized.Although all drugs are carefully tested before they are licensed for use, they carry side effect risks. Some side effects, such as Tubulointerstitial Nephritis, may become evident only after a product is in use by the general population.
Gatifloxacin Side Effect Report#6230708-7
Renal Failure, Rhabdomyolysis, Thrombocytopenia
This Renal Failure side effect was reported by a health professional from India. A 50-year-old male patient (weight:NA) experienced the following symptoms/conditions: renal failure.The patient was prescribed Gatifloxacin (drug dosage: NA), which was initiated on NS. Concurrently used drugs: NA..After starting to take Gatifloxacin the consumer reported adverse symptoms, such as: Renal Failure, Rhabdomyolysis, ThrombocytopeniaThese side effects may potentially be related to Gatifloxacin.
Gatifloxacin Side Effect Report#5934062-7
Anaphylactic Shock, Blood Creatine Phosphokinase Increased, C-reactive Protein Increased, White Blood Cell Count Increased
This is a report of a 78-year-old male patient (weight: NA) from Japan, suffering from the following health symptoms/conditions: urinary tract infection,urethritis,benign prostatic hyperplasia, who was treated with Gatifloxacin (dosage: NA, start time:
Jun 07, 2008), combined with: NA. and developed a serious reaction and side effect(s): Anaphylactic Shock, Blood Creatine Phosphokinase Increased, C-reactive Protein Increased, White Blood Cell Count Increased after the beginning of treatment. This case can indicate the possible existence of increased vulnerability to Gatifloxacin treatment in male patients, resulting in Anaphylactic Shock side effect. The patient was hospitalized.
Gatifloxacin Side Effect Report#5933001-2
Dizziness, Malaise, Rhabdomyolysis
This report suggests a potential Gatifloxacin Dizziness side effect(s) that can have serious consequences. A 93-year-old male patient (weight: NA) from Japan was diagnosed with the following symptoms/conditions: prostatitis and used Gatifloxacin (dosage: 100 Mg From Feb 2008-02mar2008.) starting
Sep 01, 2008. After starting Gatifloxacin the patient began experiencing various side effects, including: Dizziness, Malaise, RhabdomyolysisAdditional drugs used concurrently:
  • Flivas
  • Mevalotin
  • Marzulene-s
  • Zyloric
The patient was hospitalized. Although Gatifloxacin demonstrated significant improvements in a number of clinically relevant cases, troublesome symptoms, such as Dizziness, may still occur.
Gatifloxacin Side Effect Report#5927864-4
Hypoglycaemia
This Hypoglycaemia problem was reported by a physician from Japan. A 80-year-old male patient (weight: NA) was diagnosed with the following symptoms/conditions: urinary tract infection. On
Aug 29, 2008 this consumer started treatment with Gatifloxacin (dosage: NA). The following drugs were being taken at the same time:
  • Amaryl
  • Reniveze
  • Tamsulosin Hcl
  • Digestive Enzyme
  • Brotizolam
  • Rasenazolin
When using Gatifloxacin, the patient experienced the following unwanted symptoms/side effects: HypoglycaemiaThe patient was hospitalized.Although all drugs are carefully tested before they are licensed for use, they carry side effect risks. Some side effects, such as Hypoglycaemia, may become evident only after a product is in use by the general population.
Gatifloxacin Side Effect Report#5923348-8
Hypoglycaemia
This Hypoglycaemia side effect was reported by a physician from Japan. A 80-year-old male patient (weight:NA) experienced the following symptoms/conditions: urinary tract infection.The patient was prescribed Gatifloxacin (drug dosage: NA), which was initiated on
Aug 29, 2008. Concurrently used drugs:
  • Amaryl
  • Reniveze
  • Tamsulosin Hcl
  • Digestive Enzyme
  • Brotizolam
  • Rasenazolin
.After starting to take Gatifloxacin the consumer reported adverse symptoms, such as: HypoglycaemiaThese side effects may potentially be related to Gatifloxacin. The patient was hospitalized.
Gatifloxacin Side Effect Report#5923240-9
Hypoglycaemia
This is a report of a 79-year-old male patient (weight: NA) from Japan, suffering from the following health symptoms/conditions: bronchitis, who was treated with Gatifloxacin (dosage: NA, start time:
Nov 20, 2004), combined with:
  • Mucodyne (Formulation - Tablet.)
  • Ibuprofen (Formulation - Tablet.)
  • Daonil (Formulation - Tablet.)
  • Coldrin (Formulation - Tablet.)
  • Nicergoline (Formulation - Tablet.)
  • Tenormin (Formulation - Tablet.)
  • Panaldine (Formulation - Tablet.)
  • Trichlormethiazide (Formulation - Tablet.)
and developed a serious reaction and side effect(s): Hypoglycaemia after the beginning of treatment. This case can indicate the possible existence of increased vulnerability to Gatifloxacin treatment in male patients, resulting in Hypoglycaemia side effect. The patient was hospitalized.
Gatifloxacin Side Effect Report#5916573-3
Dizziness, Malaise, Rhabdomyolysis
This report suggests a potential Gatifloxacin Dizziness side effect(s) that can have serious consequences. A 93-year-old male patient (weight: NA) from Japan was diagnosed with the following symptoms/conditions: prostatitis and used Gatifloxacin (dosage: 100 Mg From Feb 2008-02mar2008.) starting
Sep 01, 2008. After starting Gatifloxacin the patient began experiencing various side effects, including: Dizziness, Malaise, RhabdomyolysisAdditional drugs used concurrently:
  • Flivas
  • Pravastatin Sodium
  • Marzulene-s
  • Zyloric
The patient was hospitalized. Although Gatifloxacin demonstrated significant improvements in a number of clinically relevant cases, troublesome symptoms, such as Dizziness, may still occur.
Gatifloxacin Side Effect Report#5904648-4
Hypoglycaemia
This Hypoglycaemia problem was reported by a physician from Japan. A 80-year-old male patient (weight: NA) was diagnosed with the following symptoms/conditions: urinary tract infection. On
Aug 29, 2008 this consumer started treatment with Gatifloxacin (dosage: NA). The following drugs were being taken at the same time:
  • Amaryl
  • Enalapril Maleate
  • Tamsulosin Hcl
  • Digestive Enzyme
  • Brotizolam
  • Cefazolin Sodium
When using Gatifloxacin, the patient experienced the following unwanted symptoms/side effects: HypoglycaemiaThe patient was hospitalized.Although all drugs are carefully tested before they are licensed for use, they carry side effect risks. Some side effects, such as Hypoglycaemia, may become evident only after a product is in use by the general population.
Gatifloxacin Side Effect Report#5889206-2
Hypoglycaemia
This Hypoglycaemia side effect was reported by a physician from Japan. A 80-year-old male patient (weight:NA) experienced the following symptoms/conditions: urinary tract infection.The patient was prescribed Gatifloxacin (drug dosage: NA), which was initiated on
Aug 29, 2008. Concurrently used drugs: NA..After starting to take Gatifloxacin the consumer reported adverse symptoms, such as: HypoglycaemiaThese side effects may potentially be related to Gatifloxacin. The patient was hospitalized.
Gatifloxacin Side Effect Report#5878994-7
Blood Glucose Increased
This is a report of a 41-year-old male patient (weight: NA) from Japan, suffering from the following health symptoms/conditions: mycobacterial infection, who was treated with Gatifloxacin (dosage: NA, start time:
May 22, 2008), combined with:
  • Luprac (Dose Form-tablets)
  • Clarithromycin (Dose Form-tablets)
  • Spironolactone (Dose Form-tablets)
  • Glucoscan (Dose Form-tablets)
  • Tracleer (Dose Form-tablets, Dose Reduced From 08-jun-2008)
  • Famotidine (Dose Form-tablets)
  • Lasix (Dose Form-tablets)
  • Dextrose 5% (5%glucose 250ml.)
and developed a serious reaction and side effect(s): Blood Glucose Increased after the beginning of treatment. This case can indicate the possible existence of increased vulnerability to Gatifloxacin treatment in male patients, resulting in Blood Glucose Increased side effect.


1 of 15 


The appearance of Gatifloxacin on this list does not mean that FDA has concluded that the drug has the listed risk. It means that FDA has identified a potential safety issue, but it does not mean that FDA has found a causal relationship between the drug and the listed risk.

Track Your Side Effects

Note Your Observations

It is really important to keep track of your health symptoms, right from the time you start a new medicine. You can do it any way you prefer: in a notebook, in a computer file or using our online tool. You should also note down any other medicines you are taking at the same time, because there could be an interaction between these medicines.

Why Your Notes are Important

Your notes could be helpful in several ways:

  • You can use them to remind you of details that may alert your health care professional(s) to a problem
  • You will have a record to refer to in the future, in case you are ever prescribed the same medicine again

  • Log Form

    You can use the following log form to write down important information, like the date and time you experienced a side effect and your symptoms, how strong the symptoms were, and any other medicines you were using.

    Medicine Name and Dosage:
    Side Effects Scale Date & Time Other Medicine(s) or Treatment(s)
    Scale: 1 = very mild to 10 = very bad

    Side effects reports are analyzed to discover potential health product safety signals. Some important reactions may take an extremely long time to develop or occur infrequently. Continued monitoring of adverse reactions is thus essential to maintain a comprehensive safety and effectiveness profile of health products.

    You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.

    Gatifloxacin reports list potential signals of serious risks and new safety information that were identified using the FDA Adverse Event Reporting System (FAERS).
    FAERS is a database that contains information on adverse event and medication errors reports submitted to FDA by healthcare professionals (such as physicians, pharmacists, nurses and others), consumers (such as patients, family members, layers and others) and manufacturers.

    Discuss Gatifloxacin Side Effects

    Did You Have a Gatifloxacin Side Effect?

    Yes, Severe
    Yes, Moderate
    Yes, Minor
    No

    How Effective is Gatifloxacin for You?

    Exceeded Expectations
    Effective
    Somewhat Effective
    Not Effective

    Gatifloxacin Safety Alerts, Active Ingredients, Usage Information

    NDC50383-189
    TypeHUMAN PRESCRIPTION DRUG
    Proprietary NameGatifloxacin
    NameGatifloxacin
    Dosage FormSOLUTION/ DROPS
    RouteOPHTHALMIC
    On market since20141006
    LabelerHi-Tech Pharmacal Co., Inc.
    Active Ingredient(s)GATIFLOXACIN ANHYDROUS
    Strength(s)5
    Unit(s)mg/mL
    Pharma ClassQuinolone Antimicrobial [EPC],Quinolones [Chemical/Ingredient]

    More About Gatifloxacin

    Side Effects reported to FDA: 366

    Gatifloxacin safety alerts: 2006

    Reported deaths: 14

    Reported hospitalizations: 197

    Tequin (gatifloxacin)

    Audience: Healthcare professionals and patients

    [Posted 02/16/2006] BMS notified FDA and healthcare professionals about proposed changes to the prescribing information for Tequin, including an updating of the existing WARNING on hypoglycemia (low blood sugar) and hyperglycemia (high blood sugar), and a CONTRAINDICATION for use in diabetic patients. The changes also include information identifying other risk factors for developing low blood sugar and high blood sugar, including advanced age, renal insufficiency, and concomitant glucose-altering medications while taking Tequin. The proposed changes are highlighted in the following "Dear Healthcare Provider" letter issued by BMS. Specific wording of these additions and revisions to the labeling is pending FDA review and approval.

    [February 15, 2006 ?? Letter ?? BMS]

    Latest Gatifloxacin clinical trials